Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate Cancer

NCT02074137 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Metastatic

Interventions

DRUG: CABAZITAXEL XRP6258
DRUG: Prednisone
DRUG: Prednisolone

Sponsor

Sanofi